View More Recent Stories

Mar 2, 2017 08:32AM Bioverativ Inc. (BIVV) Appoints Anna Protopapas to Board of Directors
Mar 2, 2017 08:30AM Anna Protopapas to Join Bioverativ Board of Directors
Mar 2, 2017 07:05AM Bioverativ (BIVV), Sobi Announced Published Long-term Safety and Efficacy Extension Study Data of ALPROLIX
Mar 2, 2017 07:00AM Long-term Safety and Efficacy Extension Study Data of ALPROLIX® for Hemophilia B Published in Thrombosis and Haemostasis
Feb 23, 2017 02:33PM Bioverativ to Present at the Cowen and Company 37th Annual Health Care Conference
Feb 14, 2017 10:00AM Bioverativ (Nasdaq: BIVV) to Ring The Nasdaq Stock Market Opening Bell
Feb 8, 2017 02:17PM Bioverativ to Present at the Leerink Partners 6th Annual Global Healthcare Conference
Feb 2, 2017 07:46AM Swedish Orphan Biovitrum AB - Long-term Safety and Efficacy Data of Extended Half-life Therapy Alprolix in Children With Haemophilia B Published in The Lancet Haematology
Feb 2, 2017 07:30AM Long-Term Safety and Efficacy Data of Extended Half-Life Therapy ALPROLIX® in Children with Hemophilia B Published in The Lancet Haematology
Feb 1, 2017 07:33AM Biogen (BIIB) Completes Separation of Bioverativ (BIVV)
Feb 1, 2017 03:09AM Sobi and Bioverativ to Reveal new Long-term Safety and Efficacy Data of Elocta® and Alprolix® at EAHAD
Dec 22, 2016 04:39PM Biogen (BIIB) Form 10 for Bioverativ Spin Declared Effective
Dec 20, 2016 04:02PM Biogen (BIIB) Approves Separation of Bioverativ (BIVV); Declares Special Dividend
View More Recent Stories